Virginia Prescription Injuries
Millions of Americans, including thousands of patients across Virginia, take prescription drugs to aid in the treatment of various medical conditions such as arthritis, severe pain, high cholesterol, mental disorders and heart problems. When consumers are directed by their physicians to use a specific pharmaceutical product, they trust that the medication will improve their condition.
Unfortunately, many of the drugs that are hitting the market are being released without adequate testing. Prescription drug injury cases have been making news recently as the result of recalls and warnings over serious health risks and side effects, including heart attacks, stroke, seizures, mental confusion, and suicidal thoughts or behavior.
Fortunately, drug manufactures can be held accountable for their actions. Through aggressive litigation, consumers in VA who have been harmed by prescription drugs can receive the compensation they deserve. Manufacturers of such drugs as Bextra, Vioxx, Celebrex, and Accutane have gone to court, and victims have received compensation in class-action lawsuits.
In addition to representing the direct victims of these devastating injuries, many Virginia prescription injury lawyers also represent the families of wrongful death victims who have died as a result of taking dangerous drugs.
If you or someone you love has been harmed by a prescription drug or product, please let your voice be heard. Raising awareness about the dangers and risks of pharmaceutical products can help save thousands of others from harm. A VA prescription drug injury attorney can advise you on what actions you need to take. Do not hesitate to call today; most consultations are free.
Contact a Mesothelioma attorney today to discuss your case:
FDA News Headlines
FDA News & Notes - Week of February 6, 2012
Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation for the Crofelemer NDA for Treatment of ...
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment for the Contrave® Outcomes Trial
FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell ...
ZIOPHARM Announces FDA Acceptance of IND for Oral Palifosfamide
Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
FDA: Limited Ban on Cephalosporin Use in Major Food-Producing Animals [Medical News & Perspectives]
NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of ...
ADDING MULTIMEDIA FDA Approves KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic ...
FDA mulls Amgen drug shift
